George W. Lucier - Publications, H-index & Citations

George W. Lucier

机构信息待补充

59H指数

295论文数

1.2W被引数

收录论文 22

发表时间

Endocrine disrupting chemicals research program of the US Environmental Protection Agency: Summary of a peer-review report

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2006-08-01

OAAI

Harding, Anna K.; Daston, George P.; Boyd, Glen R.; Lucier, George W.; Safe, Stephen H.; Stewart, Juarine; Tillitt, Donald E.; Van der Kraak, Glen

A PERSPECTIVE ON BIOLOGICALLY-BASED APPROACHES TO DIOXIN RISK ASSESSMENT

RISK ANALYSIS

IF3.3

2006-05-29

PREAI

GREENLEE, WF; ANDERSEN, ME; LUCIER, GW

Human consumption of methyleugenol and its elimination from serum

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2004-05-01

OAAI

Schecter, A; Lucier, GW; Cunningham, ML; Abdo, KM; Blumenthal, G; Silver, AG; Melnick, R; Portier, C; Barr, DB; Barr, JR; Stanfill, SB; Patterson, DG; Needham, LL; Stopford, W; Masten, S; Mignogna, J; Tung, KC

Retrospective

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2001-09-01

PREAI

Tart, KT; Lucier, GW

Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2001-05-25

PREAI

Wyde, ME; Wong, VA; Kim, AH; Lucier, GW; Walker, NJ

Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced tumor promotion by 17β-estradiol in female Sprague-Dawley rats

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2001-05-01

PREAI

Wyde, ME; Eldridge, SR; Lucier, GW; Walker, NJ

Levels of seven urinary phthalate metabolites in a human reference population

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2000-10-01

592

OAAI

Blount, BC; Silva, MJ; Caudill, SP; Needham, LL; Pirkle, JL; Sampson, EJ; Lucier, GW; Jackson, RJ; Brock, JW

Endotoxin (lipopolysaccharide)-induced nitric oxide production in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated Fischer rats:: Detection of nitrosyl hemoproteins by EPR spectroscopy

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2000-09-22

PREAI

Glover, RE; Germolec, DR; Patterson, R; Walker, NJ; Lucier, GW; Mason, RP

Strategies for assessing the implications of malformed frogs for environmental health

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

2000-01-01

OAAI

Burkhart, JG; Ankley, G; Bell, H; Carpenter, H; Fort, D; Gardiner, D; Gardner, H; Hale, R; Helgen, JC; Jepson, P; Johnson, D; Lannoo, M; Lee, D; Lary, J; Levey, R; Magner, J; Meteyer, C; Shelby, MD; Lucier, G

Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

1999-02-01

PREAI

Walker, NJ; Portier, CJ; Lax, SF; Crofts, FG; Li, Y; Lucier, GW; Sutter, TR

Induction of mortality and malformation in Xenopus laevis embryos by water sources associated with field frog deformities

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1998-12-01

OAAI

Burkhart, JG; Helgen, JC; Fort, DJ; Gallagher, K; Bowers, D; Propst, TL; Gernes, M; Magner, J; Shelby, MD; Lucier, G

Current approaches toward chemical mixture studies at the National Institute of Environmental Health Sciences and the US National Toxicology Program 国家环境健康科学研究所和美国国家毒理学计划目前对化学混合物研究的方法

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1998-12-01

OAAI

Bucher, JR; Lucier, G

Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1998-04-01

OAAI

Jung, D; Berg, PA; Edler, L; Ehrenthal, W; Fenner, D; Flesch-Janys, D; Huber, C; Klein, R; Koitka, C; Lucier, G; Manz, A; Muttray, A; Needham, L; Päpke, O; Pietsch, M; Portier, C; Patterson, D; Prellwitz, W; Rose, DM; Thews, A; Konietzko, J

Animal models of human response to dioxins

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1998-04-01

OAAI

Grassman, JA; Masten, SA; Walker, NJ; Lucier, GW

The US federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1998-03-01

OAAI

Reiter, LW; DeRosa, C; Kavlock, RJ; Lucier, G; Mac, MJ; Melillo, J; Melnick, RL; Sinks, T; Walton, BT

Concentrations of dioxin 20 years after Seveso

LANCET

IF88.5

1997-06-01

PREAI

Landi, MT; Needham, LL; Lucier, G; Mocarelli, P; Bertazzi, PA; Caporaso, N

Research needs for the risk assessment of health and environmental effects of endocrine disruptors: A report of the US EPA-sponsored workshop

ENVIRONMENTAL HEALTH PERSPECTIVES

IF9.8

1996-08-01

1.1K

OAAI

Kavlock, RJ; Daston, GP; DeRosa, C; FennerCrisp, P; Gray, LE; Kaattari, S; Lucier, G; Luster, M; Mac, MJ; Maczka, C; Miller, R; Moore, J; Rolland, R; Scott, G; Sheehan, DM; Sinks, T; Tilson, HA

Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

1996-05-01

PREAI

Portier, CJ; Sherman, CD; Kohn, M; Edler, L; KoppSchneider, A; Maronpot, RM; Lucier, G

Differences in binding of epidermal growth factor to liver membranes of TCDD-resistant and TCDD-sensitive rats after a single dose of TCDD

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

IF4.2

1996-04-01

PREAI

Tuomisto, J; Sewall, CH; Unkila, M; Pohjanvirta, R; Clark, GC; Viluksela, M; Rozman, K; Lucier, GW